clinical study of charak digestive syrup in the management of Amplapitta

open labelled clinical study of charak digestive syrup in the management of Amplapitta - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2023/12/060576

Enrollment

Registered

2023-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: participate having sign and symptoms of amlapitta such as amlaudgar and Daha

Exclusion criteria

Exclusion criteria: below 20 and above 60 years known case of intestinal kochs,cholecystitis addicted alcohol gastric ulcer ,ibs

Design outcomes

Primary

Measure	Time frame
Relief from symptoms of indigestionTimepoint: 4 weeks	—

Secondary

Measure	Time frame
Relief from symptoms of indigestionTimepoint: Ã¢â?¬Â¢ Study assessment of all patients will be done at baseline, on 7th day then on 14th as well as on 21st day and at the end of the study i.e. 28th day	—

Countries

India

Contacts

Public ContactDr Jai Kiran Kini

Dr. G. D. Pol foundations YMT Ayurvedic Medical College

vd.jaikini@gmail.com9869046901

Outcome results